Virological failure and HIV-1 drug resistance mutations among naive and antiretroviral pre-treated patients entering the ESTHER program of Calmette Hospital in Cambodia

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Barennes, Hubert ^a,b   Guillet, Stéphanie ^a,c   Limsreng, Setha ^d   Him, Sovanvatey ^a,d   Nouhin, Janin ^a,e   Hak, Chanroeurn ^a,d   Srun, Chanvatey ^d   Viretto, Gerald ^a   Ouk, Vara ^a,d   Delfraissy, Jean Francois ^a,c   Ségéral, Olivier ^a,c  

^a Agence Nationale de Recherche Sur le VIH et Les Hepatites ^*  (Cambodia)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c BICÊTRE HOSPITAL   (France)

^d Hopital Calmette   (Cambodia)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS TENOFOVIR DISOPROXIL; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; NUCLEOSIDE; NUCLEOTIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; THYMIDINE DERIVATIVE; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ALGORITHM; ANTIVIRAL RESISTANCE; ARTICLE; CAMBODIA; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTPATIENT DEPARTMENT; RETROSPECTIVE STUDY; VIREMIA; VIRUS LOAD; VIRUS MUTATION; GENETICS; HIV INFECTIONS; MIDDLE AGED; MUTATION; TREATMENT FAILURE;

ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CAMBODIA; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VIRAL LOAD;

EID: 84940322719     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105736     Document Type: Article

References (38)

1. Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, et al. (2012) Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet 380: 1250-1258. S0140- 6736(12)61038-1 [pii];10.1016/S0140-6736(12)61038-1 [doi].
2. WHO (2009) Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. WHO. Available: http://www.who.int/hiv/pub/arv/advice/ en/.
3. WHO (2010) Antiretroviral therapy for HIV infection in children: towards universal access-recommendations for a public health approach, 2010 revision.
4. van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, et al. (2009) Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria. Trop Med Int Health 14: 856-861. TMI2309 [pii];10.1111/j.1365-3156.2009.02309.x [doi].
5. Westley BP, DeLong AK, Tray CS, Sophearin D, Dufort EM, et al. (2012) Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian children. Clin Infect Dis 55: 432-440. cis433 [pii];10.1093/cid/cis433 [doi].
6. Coetzer M, Westley B, Delong A, Tray C, Sophearin D, et al. (2013) Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines. AIDS Res Hum Retroviruses 29: 985-992. 10.1089/AID.2013.0025 [doi].
7. Zolfo M, Schapiro JM, Phan V, Koole O, Thai S, et al. (2011) Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01-AE-infected cohort. AIDS Res Hum Retroviruses 27: 727-735. 10.1089/AID.2010.0037 [doi].
8. Arnedo M, Alonso E, Eisenberg N, Ibanez L, Ferreyra C, J et al. (2012) Monitoring HIV viral load in resource limited settings: still a matter of debate? PLoS One 7: e47391. 10.1371/journal.pone.0047391 [doi];PONE-D-12-15685 [pii].
9. WHO (2013) Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. http://www.who.int/hiv/pub/guidelines/ arv2013/download/en/.
10. Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, et al. (2011) Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr 56: 44-50. 10.1097/QAI.0b013e3181fbcbf7 [doi].
11. Stricker SM, Fox KA, Baggaley R, Negussie E, de PS, et al. (2013) Retention in Care and Adherence to ART are Critical Elements of HIV Care Interventions. AIDS Behav. 10.1007/s10461-013-0598-6 [doi].
12. WHO, United Nations Children's Fund (2011) Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV/AIDS Response: Epidemic Update and Health Sectors Progress Towards Universal Access. Progress Report 2011.
13. NCHADS, Chhea Chhorvann, Saphonn Vonthanak (2011) Estimations and Projections of HIV/AIDS in Cambodia 2010-2015. 1-58.
14. NCHADS (2012) Conceptual Framework for Elimination of New HIV infections in Cambodia by 2020. 1-22.
15. NCHADS (2013) NCHADS 3Quaterly report 2013. 1-8.
16. NCHADS (2013) Fourth quaterly report 2012.
17. NCHADS (2012) National guidelines for the use of antiretroviral therapy for HIV infection in adults and adolescents.
18. Chetchotisakd P, Anunnatsiri S, Kiertiburanakul S, Sutthent R, Anekthananon T, et al. (2006) High rate multiple drug resistances in HIV-infected patients failing nonnucleoside reverse transcriptase inhibitor regimens in Thailand, where subtype A/E is predominant. J Int Assoc Physicians AIDS Care (Chic) 5: 152-156. 5/4/152 [pii];10.1177/1545109706294288 [doi].
19. Ngo-Giang-Huong N, Jourdain G, Amzal B, Gad P, Lertkoonalak R, et al. (2011) Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis. PLoS One 6: e27427. 10.1371/journal.pone.0027427 [doi];PONE-D-10-04651 [pii].
20. Sungkanuparph S, Sukasem C, Kiertiburanakul S, Pasomsub E, Chantratita W (2012) Emergence of HIV-1 drug resistance mutations among antiretroviralnaive HIV-1-infected patients after rapid scaling up of antiretroviral therapy in Thailand. J Int AIDS Soc 15: 12. 1758-2652-15-12 [pii];10.1186/1758-2652-15-12 [doi].
21. Cambodia Ethical Comitee (2011) Cambodian Ethical Guidelines for Health Research Involving Human Subjects. Part III, article 1.
22. Nouhin J, Ngin S, Martin PR, Marcy O, Kruy L, et al. (2009) Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in Cambodia. AIDS Res Hum Retroviruses 25: 543-545. 10.1089/aid.2008.0305 [doi].
23. WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents. WHO. Available: http://www.who.int/hiv/pub/guidelines/ artadultguidelines.pdf.
24. ANRS-AC 11 Resistance Group (2007) ANRS - AC 11 Genotype interpretation: nucleoside and nucleotide reverse transcriptase inhibitors.
25. WHO (2010) Antiretroviral therapy for HIV infection in children: towards universal access-recommendations for a public health approach, 2010 revision.
26. Nouhin J, Madec Y, Ngo-Giang-Huong N, Ferradini L, Nerrienet E (2013) Increased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in Cambodia. PLoS One 8: e73744. 10.1371/journal.pone.0073744 [doi];PONE-D-13-18830 [pii].
27. Ferradini L, Laureillard D, Prak N, Ngeth C, Fernandez M, et al. (2007) Positive outcomes of HAART at 24 months in HIV-infected patients in Cambodia. AIDS 21: 2293-2301. 10.1097/QAD.0b013e32828cc8b7 [doi];00002030- 200711120-00005 [pii].
28. Isaakidis P, Raguenaud ME, Te V, Tray CS, Akao K, et al. (2010) High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J Int AIDS Soc 13: 11. 1758-2652-13-11 [pii];10.1186/1758-2652-13-11 [doi].
29. Janssens B, Raleigh B, Soeung S, Akao K, Te V, et al. (2007) Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics 120: e1134-e1140. peds.2006-3503 [pii];10.1542/peds.2006-3503 [doi].
30. Pujades-Rodriguez M, Schramm B, Som L, Nerrienet E, Narom P, et al. (2011) Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia. Trop Med Int Health 16: 205-213. 10.1111/j.1365-3156.2010.02689.x [doi].
31. Segeral O, Limsreng S, Nouhin J, Hak C, Ngin S, et al. (2011) Short communication: three years follow-up of first-line antiretroviral therapy in cambodia: negative impact of prior antiretroviral treatment. AIDS Res Hum Retroviruses 27: 597-603. 10.1089/AID.2010.0125 [doi].
32. Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM (2010) Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis 10: 155-166. S1473-3099(09)70328-7 [pii];10.1016/S1473-3099(09)70328-7 [doi].
33. Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, et al. (2014) Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the world health organization public health approach in sub-saharan Africa and southeast Asia. Clin Infect Dis 58: 99-109. cit627 [pii];10.1093/cid/cit627 [doi].
34. Ferradini L, Ouk V, Segeral O, Nouhin J, Dulioust A, et al. (2011) High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia. J Int AIDS Soc 14: 14. 1758-2652-14-14 [pii];10.1186/1758-2652-14-14 [doi].
35. Nerrienet E, Nouhin J, Ngin S, Segeral O, Ken S, et al. (2012) HIV-1 protease inhibitors resistance profiles in patients with virological failure on LPV/r-based 2nd line regimen in Cambodia. J AIDS Clinic Res.
36. Wittkop L, Gunthard HF, de WF, Dunn D, Cozzi-Lepri A, et al. (2011) Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study. Lancet Infect Dis 11: 363-371. S1473-3099(11)70032-9 [pii];10.1016/S1473-3099(11)70032-9 [doi].
37. Stadeli KM, Richman DD (2013) Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review. Antivir Ther 18: 115-123. 10.3851/IMP2437 [doi].
38. Segeral O, Madec Y, Ban B, Ouk V, Hak CR, et al. (2010) Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia. AIDS Res Treat 2010: 142076. 10.1155/2010/142076 [doi].